Arvin, A. M., P. Fast, M. Myers, S. Plotkin, R. Rabinovich and C. National Vaccine Advisory (2004). "Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee." Clin Infect Dis 39(2): 233-239.


Biorn, A. C., S. Cocklin, N. Madani, Z. Si, T. Ivanovic, J. Samanen, D. I. Van Ryk, R. Pantophlet, D. R. Burton, E. Freire, J. Sodroski and I. M. Chaiken (2004). "Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions." Biochemistry 43(7): 1928-1938.


Bower, J. F., X. Yang, J. Sodroski and T. M. Ross (2004). "Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d." J Virol 78(9): 4710-4719.


Buchbinder, S. P., B. Metch, S. E. Holte, S. Scheer, A. Coletti and E. Vittinghoff (2004). "Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation." J Acquir Immune Defic Syndr 36(1): 604-612.


Burton, D. R., R. C. Desrosiers, R. W. Doms, M. B. Feinberg, R. C. Gallo, B. Hahn, J. A. Hoxie, E. Hunter, B. Korber, A. Landay, M. M. Lederman, J. Lieberman, J. M. McCune, J. P. Moore, N. Nathanson, L. Picker, D. Richman, C. Rinaldo, M. Stevenson, D. I. Watkins, S. M. Wolinsky and J. A. Zack (2004). "Public health. A sound rationale needed for phase III HIV-1 vaccine trials." Science 303(5656): 316.


Burton, D. R., R. C. Desrosiers, R. W. Doms, W. C. Koff, P. D. Kwong, J. P. Moore, G. J. Nabel, J. Sodroski, I. A. Wilson and R. T. Wyatt (2004). "HIV vaccine design and the neutralizing antibody problem." Nat Immunol 5(3): 233-236.


Burton, D. R., R. C. Desrosiers, P. R. Johnson and W. C. Koff (2004). "An AIDS vaccine: no time to give up." Lancet 364(9449): 1938.


Casimiro, D. R., A. J. Bett, T. M. Fu, M. E. Davies, A. Tang, K. A. Wilson, M. Chen, R. Long, T. McKelvey, M. Chastain, S. Gurunathan, J. Tartaglia, E. A. Emini and J. Shiver (2004). "Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors." J Virol 78(20): 11434-11438.

Cohen J, P. W., Berkley S, Calandra T, Clumeck N, Finch RG, Hammer SM, Holland SM, Kiehn TE, Maki DG, McAdam K, Norrby SR, Opal SM, Ronald AR, Solberg CO, Verhoef J (2004). Infectious Diseases. London, Mosby.       

Cole, K. S., J. D. Steckbeck, J. L. Rowles, R. C. Desrosiers and R. C. Montelaro (2004). "Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3." J Virol 78(3): 1525-1539.

Davis, C. W. and R. W. Doms (2004). "HIV transmission: closing all the doors." J Exp Med 199(8): 1037-1040.


Desrosiers, R. C. (2004). "Prospects for an AIDS vaccine." Nat Med 10(3): 221-223.


Doms, R. W. (2004). "Unwelcome guests with master keys: how HIV enters cells and how it can be stopped." Top HIV Med 12(4): 100-103.


Doms, R. W. (2004). "Viral entry denied." N Engl J Med 351(8): 743-744.


Estcourt, M. J., A. J. McMichael and T. Hanke (2004). "DNA vaccines against human immunodeficiency virus type 1." Immunol Rev 199: 144-155.


Evans, D. T., J. E. Bricker and R. C. Desrosiers (2004). "A novel approach for producing lentiviruses that are limited to a single cycle of infection." J Virol 78(21): 11715-11725.


Excler JL (2004). HIV vaccine development in South-East Asia. AIDS in Asia – The Challenge Ahead. N. J. P. New Delhi., SAGE Publications: 360-373.   

Friedrich, T. C., E. J. Dodds, L. J. Yant, L. Vojnov, R. Rudersdorf, C. Cullen, D. T. Evans, R. C. Desrosiers, B. R. Mothe, J. Sidney, A. Sette, K. Kunstman, S. Wolinsky, M. Piatak, J. Lifson, A. L. Hughes, N. Wilson, D. H. O'Connor and D. I. Watkins (2004). "Reversion of CTL escape-variant immunodeficiency viruses in vivo." Nat Med 10(3): 275-281.


Friedrich, T. C., A. B. McDermott, M. R. Reynolds, S. Piaskowski, S. Fuenger, I. P. De Souza, R. Rudersdorf, C. Cullen, L. J. Yant, L. Vojnov, J. Stephany, S. Martin, D. H. O'Connor, N. Wilson and D. I. Watkins (2004). "Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts." J Virol 78(18): 10064-10073.


Grundner, C., M. Pancera, J. M. Kang, M. Koch, J. Sodroski and R. Wyatt (2004). "Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins." Virology 330(1): 233-248.


Haigwood, N. L., D. C. Montefiori, W. F. Sutton, J. McClure, A. J. Watson, G. Voss, V. M. Hirsch, B. A. Richardson, N. L. Letvin, S. L. Hu and P. R. Johnson (2004). "Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies." J Virol 78(11): 5983-5995.


Hazuda, D. J., N. J. Anthony, R. P. Gomez, S. M. Jolly, J. S. Wai, L. Zhuang, T. E. Fisher, M. Embrey, J. P. Guare, Jr., M. S. Egbertson, J. P. Vacca, J. R. Huff, P. J. Felock, M. V. Witmer, K. A. Stillmock, R. Danovich, J. Grobler, M. D. Miller, A. S. Espeseth, L. Jin, I. W. Chen, J. H. Lin, K. Kassahun, J. D. Ellis, B. K. Wong, W. Xu, P. G. Pearson, W. A. Schleif, R. Cortese, E. Emini, V. Summa, M. K. Holloway and S. D. Young (2004). "A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase." Proc Natl Acad Sci U S A 101(31): 11233-11238.


Hazuda, D. J., S. D. Young, J. P. Guare, N. J. Anthony, R. P. Gomez, J. S. Wai, J. P. Vacca, L. Handt, S. L. Motzel, H. J. Klein, G. Dornadula, R. M. Danovich, M. V. Witmer, K. A. Wilson, L. Tussey, W. A. Schleif, L. S. Gabryelski, L. Jin, M. D. Miller, D. R. Casimiro, E. A. Emini and J. W. Shiver (2004). "Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques." Science 305(5683): 528-532.


Huang, C. C., M. Venturi, S. Majeed, M. J. Moore, S. Phogat, M. Y. Zhang, D. S. Dimitrov, W. A. Hendrickson, J. Robinson, J. Sodroski, R. Wyatt, H. Choe, M. Farzan and P. D. Kwong (2004). "Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120." Proc Natl Acad Sci U S A 101(9): 2706-2711.


Kaydos-Daniels, S. C., W. C. Miller, I. Hoffman, M. A. Price, F. Martinson, D. Chilongozi, D. Namakwha, S. Gama, S. Phakati, M. S. Cohen and M. M. Hobbs (2004). "The use of specimens from various genitourinary sites in men, to detect Trichomonas vaginalis infection." J Infect Dis 189(10): 1926-1931.

Kieny, M. P., J. L. Excler and M. Girard (2004). "Research and development of new vaccines against infectious diseases." Am J Public Health 94(11): 1931-1935.


Koopman, G., D. Mortier, S. Hofman, H. Niphuis, Z. Fagrouch, S. Norley, G. Sutter, P. Liljestrom and J. L. Heeney (2004). "Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens." J Gen Virol 85(Pt 10): 2915-2924.


Kuhmann, S. E., P. Pugach, K. J. Kunstman, J. Taylor, R. L. Stanfield, A. Snyder, J. M. Strizki, J. Riley, B. M. Baroudy, I. A. Wilson, B. T. Korber, S. M. Wolinsky and J. P. Moore (2004). "Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor." J Virol 78(6): 2790-2807.


Madani, N., A. L. Perdigoto, K. Srinivasan, J. M. Cox, J. J. Chruma, J. LaLonde, M. Head, A. B. Smith, 3rd and J. G. Sodroski (2004). "Localized changes in the gp120 envelope glycoprotein confer resistance to human immunodeficiency virus entry inhibitors BMS-806 and #155." J Virol 78(7): 3742-3752.


McDermott, A. B., J. Mitchen, S. Piaskowski, I. De Souza, L. J. Yant, J. Stephany, J. Furlott and D. I. Watkins (2004). "Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates." J Virol 78(6): 3140-3144.


Mwau, M., I. Cebere, J. Sutton, P. Chikoti, N. Winstone, E. G. Wee, T. Beattie, Y. H. Chen, L. Dorrell, H. McShane, C. Schmidt, M. Brooks, S. Patel, J. Roberts, C. Conlon, S. L. Rowland-Jones, J. J. Bwayo, A. J. McMichael and T. Hanke (2004). "A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans." J Gen Virol 85(Pt 4): 911-919.


Negri, D. R., S. Baroncelli, S. Catone, A. Comini, Z. Michelini, M. T. Maggiorella, L. Sernicola, F. Crostarosa, R. Belli, M. G. Mancini, S. Farcomeni, Z. Fagrouch, M. Ciccozzi, S. Boros, P. Liljestrom, S. Norley, J. Heeney and F. Titti (2004). "Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge." J Gen Virol 85(Pt 5): 1191-1201.


Nkolola, J. P., E. G. Wee, E. J. Im, C. P. Jewell, N. Chen, X. N. Xu, A. J. McMichael and T. Hanke (2004). "Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa." Gene Ther 11(13): 1068-1080.


O'Connor, D. H., A. B. McDermott, K. C. Krebs, E. J. Dodds, J. E. Miller, E. J. Gonzalez, T. J. Jacoby, L. Yant, H. Piontkivska, R. Pantophlet, D. R. Burton, W. M. Rehrauer, N. Wilson, A. L. Hughes and D. I. Watkins (2004). "A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation." J Virol 78(24): 14012-14022.


Opalka, D., A. Pessi, E. Bianchi, G. Ciliberto, W. Schleif, M. McElhaugh, R. Danzeisen, R. Geleziunas, M. Miller, D. M. Eckert, D. Bramhill, J. Joyce, J. Cook, W. Magilton, J. Shiver, E. Emini and M. T. Esser (2004). "Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay." J Immunol Methods 287(1-2): 49-65.


Owens, C. M., B. Song, M. J. Perron, P. C. Yang, M. Stremlau and J. Sodroski (2004). "Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid." J Virol 78(10): 5423-5437.


Perron, M. J., M. Stremlau, B. Song, W. Ulm, R. C. Mulligan and J. Sodroski (2004). "TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells." Proc Natl Acad Sci U S A 101(32): 11827-11832.


Pierson, T. C., R. W. Doms and S. Pohlmann (2004). "Prospects of HIV-1 entry inhibitors as novel therapeutics." Rev Med Virol 14(4): 255-270.


Pilcher, C. D., J. J. Eron, Jr., S. Galvin, C. Gay and M. S. Cohen (2004). "Acute HIV revisited: new opportunities for treatment and prevention." J Clin Invest 113(7): 937-945.

Price, M. A., W. C. Miller, S. C. Kaydos-Daniels, I. F. Hoffman, D. Chilongozi, F. E. Martinson, D. Namakhwa, J. Malanda and M. Cohen (2004). "Trichomoniasis in men and HIV infection: data from 2 outpatient clinics at Lilongwe Central Hospital, Malawi." J Infect Dis 190(8): 1448-1455.

Reeves, J. D., J. L. Miamidian, M. J. Biscone, F. H. Lee, N. Ahmad, T. C. Pierson and R. W. Doms (2004). "Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity." J Virol 78(10): 5476-5485.

Rybarczyk, B. J., D. Montefiori, P. R. Johnson, A. West, R. E. Johnston and R. Swanstrom (2004). "Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques." J Virol 78(7): 3561-3571.


Shiver, J. W. and E. A. Emini (2004). "Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors." Annu Rev Med 55: 355-372.

Si, Z., P. Gorry, G. Babcock, C. M. Owens, M. Cayabyab, N. Phan and J. Sodroski (2004). "Envelope glycoprotein determinants of increased entry in a pathogenic simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) passaged in monkeys." AIDS Res Hum Retroviruses 20(2): 163-173.


Si, Z., N. Madani, J. M. Cox, J. J. Chruma, J. C. Klein, A. Schon, N. Phan, L. Wang, A. C. Biorn, S. Cocklin, I. Chaiken, E. Freire, A. B. Smith, 3rd and J. G. Sodroski (2004). "Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins." Proc Natl Acad Sci U S A 101(14): 5036-5041.


Song, B., M. Cayabyab, N. Phan, L. Wang, M. K. Axthelm, N. L. Letvin and J. G. Sodroski (2004). "Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease." Virology 322(1): 168-181.


Stremlau, M., C. M. Owens, M. J. Perron, M. Kiessling, P. Autissier and J. Sodroski (2004). "The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys." Nature 427(6977): 848-853.


Wang, J., G. J. Babcock, H. Choe, M. Farzan, J. Sodroski and D. Gabuzda (2004). "N-linked glycosylation in the CXCR4 N-terminus inhibits binding to HIV-1 envelope glycoproteins." Virology 324(1): 140-150.

Yang, X., V. Tomov, S. Kurteva, L. Wang, X. Ren, M. K. Gorny, S. Zolla-Pazner and J. Sodroski (2004). "Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1." J Virol 78(23): 12975-12986.


Yuan, W., S. Craig, Z. Si, M. Farzan and J. Sodroski (2004). "CD4-induced T-20 binding to human immunodeficiency virus type 1 gp120 blocks interaction with the CXCR4 coreceptor." J Virol 78(10): 5448-5457.